Moleculin Biotech Inc. | Mutual Funds
Mutual Funds that own Moleculin Biotech Inc.
Vanguard Total Stock Market Index Fund
408,934
1.52%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
229,179
0.85%
4,683
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
89,013
0.33%
0
0%
07/31/2018
iShares Micro Cap ETF
48,754
0.18%
0
0.01%
09/06/2018
Fidelity Spartan Total Market Index Fund
37,484
0.14%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
17,452
0.07%
0
0%
07/31/2018
DFA US Small Cap Portfolio
10,785
0.04%
10,785
0%
04/30/2018
Vanguard Balanced Index Fund
9,576
0.04%
0
0%
07/31/2018
| Address |
5300 Memorial Drive
Houston Texas 77007
United States
|
|
Employees
|
- |
| Website |
http://www.moleculin.com |
| Updated |
07/08/2019 |
| Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which focuses on the development of oncology drug candidates. Its Annamycin product candidate helps in the treatment of relapsed or refractory acute myeloid leukemia. The company's preclinical small molecule portfolios focus on the modulation of hard-to-target tumor cell signaling mechanisms and the metabolism of tumors. |
